Invention Grant
- Patent Title: Chimeric MOMP antigen
- Patent Title (中): 嵌合MOMP抗原
-
Application No.: US13700662Application Date: 2011-05-27
-
Publication No.: US08735543B2Publication Date: 2014-05-27
- Inventor: Sören Andersson , Åke Strid
- Applicant: Sören Andersson , Åke Strid
- Applicant Address: SE Örebro
- Assignee: Spixia Biotechnology AB
- Current Assignee: Spixia Biotechnology AB
- Current Assignee Address: SE Örebro
- Agency: Hamre, Schumann, Mueller & Larson, P.C.
- Priority: SE1050535 20100528
- International Application: PCT/EP2011/058755 WO 20110527
- International Announcement: WO2011/147975 WO 20111201
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/118 ; C07H21/04 ; C07K1/00 ; C12N1/20 ; C12N15/00 ; C12P21/06
Abstract:
The present invention regards polypeptides capable of eliciting an immunological response that is protective against Chlamydia trachomatis. The polypeptide comprises a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 2. Furthermore, production of these polypeptides and pharmaceutical compositions comprising them are also provided.
Public/Granted literature
- US20130156805A1 CHIMERIC MOMP ANTIGEN Public/Granted day:2013-06-20
Information query
